Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer
Ovarian cancer is one of the most lethal malignant gynecological tumors. More than 70% of patients with ovarian cancer are diagnosed at advanced stage. The 5-year survival in patients with advanced ovarian cancer is less than 30% because of the lack of effective biomarkers for diagnosis, prognosis,...
Main Authors: | Hong Zheng, Jia-Yu Liu, Feng-Ju Song, Ke-Xin Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2013-09-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | http://www.cancerbiomed.org/index.php/cocr/article/view/618 |
Similar Items
Similar Items
-
MicroRNAs in prostate cancer
by: Won Tae Kim, et al.
Published: (2013-03-01) -
The Role of microRNAs in Epithelial Ovarian Cancer Metastasis
by: Vu Hong Loan Nguyen, et al.
Published: (2020-09-01) -
Circulating MicroRNAs as Novel Potential Diagnostic Biomarkers for Osteosarcoma: A Systematic Review
by: Thaís Borges Gally, et al.
Published: (2021-09-01) -
Role of microRNAs in premature ovarian insufficiency
by: Ying Guo, et al.
Published: (2017-05-01) -
Circulating microRNAs as biomarkers of Chagas cardiomyopathy
by: Laura Antonietti, et al.
Published: (2023-12-01)